Inter-sectoral Collaboration for Health / Collaboration intersectorielle pour la santé

Permanent URI for this collection

Browse

Recent Submissions

Now showing 1 - 4 of 4
  • Item
    Globetrotting firms: Canada’s health biotechnology collaborations with developing countries
    (Nature America, 2009)
    A survey of Canadian biotech firms reveals that their biotech collaborations with developing countries are not only significant but also increasingly reciprocal in terms of the exchange of financial resources and technological know-how.
  • Item
    Tackling Meningitis in Africa
    (2012)
    Since the late 1990s, governments of Brazil and Cuba have been promoting scientific interaction emphasizing South-South collaborations. The Brazil-Cuba vaccine targeted the meningitis strain in Africa when vaccination stocks ran low, and subsequently the two organizations developped an inexpensive health product accessible also to the local populations. The Brazil-Cuba meningitis project was not their only collaboration to have benefited a third party. They are now jointly promoting health and development in Haiti following the 2010 earthquake and will construct hospitals, support immunization programs, and strengthen laboratories for disease surveillance in Haiti.
  • Item
    South-South collaboration in health biotechnology : growing partnerships amongst developing countries
    (IDRC, Ottawa, ON, CA, 2012) Thorsteinsdottir, Halla
    Results of this detailed study show that one in every four firms that responded to the survey stated an active collaboration with other developing countries. Findings also indicate the dual purpose of South-South collaboration: to amplify global competitiveness of leading developing countries in health biotechnology, and to strengthen regional ties in the field. Case studies are based on data collected from researchers and entrepreneurs who have direct experience in collaborations. In order to harness South-South collaborations in providing affordable options to improve health in developing countries, an increased role for international and philanthropic organisations is called for.
  • Item
    South-South entrepreneurial collaboration in health biotech
    (Nature America, 2010)
    A survey and detailed analysis of entrepreneurial collaborations among health biotech firms in developing countries reveals a surprisingly high level of collaboration but lack of emphasis on new health biotech products and processes. Although South-South collaboration in science and technology has been high on developing countries’ agendas since the 1960s, there is limited amount of empirical data derived from examining these collaborations. 288 biotech firms completed the current survey. Results show that R&D collaborations are not nearly as numerous as end-stage commercial collaborations. South-South collaborations rarely include clinical trials. This survey establishes a baseline for future studies towards effective policy making.